Payment overview · 2025
General Payments
$87.87
6 reported records · 4 companies
Healthcare provider profile · identity verified
Matthew David Roehrs, DO
Allopathic & Osteopathic Physicians|Family Medicine · COLUMBIA, MO · NPI 1740774157
Verified facts
What the public records show
CMS Open Payments records show Matthew David Roehrs, DO received $87.87 in general payments during 2025 across 6 reported records.
Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 34.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Symbicort by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 67 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $30.51 | 34.7% | 2 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $26.26 | 29.9% | 2 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $15.69 | 17.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.41 | 17.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $87.87 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $30.51 | 2 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $26.26 | 2 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $15.69 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $15.41 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 67 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
33 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
67 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1097 | 204 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1061 | 251 |
| Furosemide | Furosemide | 566 | 97 |
| Lisinopril | Lisinopril | 557 | 141 |
| Losartan Potassium | Losartan Potassium | 549 | 118 |
| Amlodipine Besylate | Amlodipine Besylate | 548 | 118 |
| Potassium Chloride | Potassium Chloride | 527 | 77 |
| Gabapentin | Gabapentin | 516 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 516 | 118 |
| Pantoprazole Sodium | Pantoprazole Sodium | 471 | 106 |
| Omeprazole | Omeprazole | 434 | 98 |
| Hydrochlorothiazide | Hydrochlorothiazide | 353 | 73 |
| Tamsulosin Hcl | Tamsulosin Hcl | 330 | 76 |
| Metformin Hcl | Metformin Hcl | 292 | 68 |
| Meloxicam | Meloxicam | 287 | 69 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 280 | 73 |
| Trazodone Hcl | Trazodone Hcl | 277 | 60 |
| Tramadol Hcl | Tramadol Hcl | 264 | 38 |
| Fluticasone Propionate | Fluticasone Propionate | 263 | 100 |
| Mirtazapine | Mirtazapine | 256 | 27 |
| Carvedilol | Carvedilol | 238 | 58 |
| Sertraline Hcl | Sertraline Hcl | 229 | 44 |
| Escitalopram Oxalate | Escitalopram Oxalate | 225 | 32 |
| Eliquis | Apixaban | 210 | 33 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 210 | 33 |
| Montelukast Sodium | Montelukast Sodium | 181 | 51 |
| Allopurinol | Allopurinol | 177 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 167 | 32 |
| Glimepiride | Glimepiride | 167 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 162 | 55 |
| Pravastatin Sodium | Pravastatin Sodium | 160 | 46 |
| Lovastatin | Lovastatin | 156 | 40 |
| Donepezil Hcl | Donepezil Hcl | 152 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 148 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 144 | 25 |
| Metformin Hcl Er | Metformin Hcl | 136 | 36 |
| Xarelto | Rivaroxaban | 135 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 134 | suppressed |
| Lorazepam | Lorazepam | 130 | 27 |
| Alendronate Sodium | Alendronate Sodium | 119 | 32 |
| Famotidine | Famotidine | 113 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 113 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 110 | 17 |
| Ezetimibe | Ezetimibe | 110 | 37 |
| Celecoxib | Celecoxib | 107 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 103 | 21 |
| Amitriptyline Hcl | Amitriptyline Hcl | 100 | 20 |
| Ozempic | Semaglutide | 100 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 100 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 99 | 15 |
| Alprazolam | Alprazolam | 98 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 98 | 23 |
| Tizanidine Hcl | Tizanidine Hcl | 97 | 43 |
| Levetiracetam | Levetiracetam | 94 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 91 | 28 |
| Amiodarone Hcl | Amiodarone Hcl | 90 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 88 | 26 |
| Warfarin Sodium | Warfarin Sodium | 88 | 17 |
| Carbamazepine Er | Carbamazepine | 85 | suppressed |
| Clonazepam | Clonazepam | 84 | 13 |
| Fenofibrate | Fenofibrate | 83 | 21 |
| Enalapril Maleate | Enalapril Maleate | 80 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 80 | 14 |
| Atenolol | Atenolol | 78 | 18 |
| Propranolol Hcl | Propranolol Hcl | 78 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 77 | 48 |
| Pioglitazone Hcl | Pioglitazone Hcl | 74 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 73 | 14 |
| Methylprednisolone | Methylprednisolone | 72 | 64 |
| Simvastatin | Simvastatin | 71 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 71 | 18 |
| Spironolactone | Spironolactone | 69 | 17 |
| Buspirone Hcl | Buspirone Hcl | 68 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 67 | suppressed |
| Jardiance | Empagliflozin | 67 | 16 |
| Prednisone | Prednisone | 67 | 31 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 64 | suppressed |
| Azithromycin | Azithromycin | 62 | 49 |
| Baclofen | Baclofen | 62 | suppressed |
| Carbamazepine | Carbamazepine | 61 | suppressed |
| Memantine Hcl | Memantine Hcl | 61 | suppressed |
| Pregabalin | Pregabalin | 61 | 11 |
| Bupropion Xl | Bupropion Hcl | 60 | suppressed |
| Chlorthalidone | Chlorthalidone | 59 | 15 |
| Estradiol | Estradiol | 58 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 57 | 36 |
| Nystatin | Nystatin | 55 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 55 | 11 |
| Venlafaxine Hcl | Venlafaxine Hcl | 55 | suppressed |
| Finasteride | Finasteride | 54 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 54 | 16 |
| Doxazosin Mesylate | Doxazosin Mesylate | 51 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | suppressed |
| Naproxen | Naproxen | 49 | 11 |
| Nabumetone | Nabumetone | 48 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 46 | suppressed |
| Latanoprost | Latanoprost | 46 | suppressed |
| Pentoxifylline | Pentoxifylline | 46 | suppressed |
| Metolazone | Metolazone | 45 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 45 | suppressed |
| Synthroid | Levothyroxine Sodium | 45 | 11 |
| Acyclovir | Acyclovir | 44 | 14 |
| Divalproex Sodium | Divalproex Sodium | 44 | suppressed |
| Glipizide | Glipizide | 44 | 12 |
| Incruse Ellipta | Umeclidinium Bromide | 42 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Cephalexin | Cephalexin | 41 | 36 |
| Irbesartan | Irbesartan | 41 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 40 | suppressed |
| Sucralfate | Sucralfate | 40 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 38 | 12 |
| Ondansetron Odt | Ondansetron | 38 | 23 |
| Testosterone Cypionate | Testosterone Cypionate | 38 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 37 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 37 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 36 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 36 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 36 | 20 |
| Dicyclomine Hcl | Dicyclomine Hcl | 35 | suppressed |
| Fentanyl | Fentanyl | 34 | suppressed |
| Mounjaro | Tirzepatide | 34 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 32 |
| Bumetanide | Bumetanide | 33 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 22 |
| Symbicort | Budesonide/Formoterol Fumarate | 33 | suppressed |
| Torsemide | Torsemide | 33 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 32 | suppressed |
| Levemir Flexpen | Insulin Detemir | 31 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 30 | suppressed |
| Novolog | Insulin Aspart | 30 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 29 | 28 |
| Carisoprodol | Carisoprodol | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 28 | 11 |
| Entresto | Sacubitril/Valsartan | 28 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 26 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 25 | suppressed |
| Mupirocin | Mupirocin | 24 | 18 |
| Topiramate | Topiramate | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 21 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 21 | 15 |
| Colchicine | Colchicine | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Creon | Lipase/Protease/Amylase | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 13 |
| Cefdinir | Cefdinir | 19 | 17 |
| Ketoconazole | Ketoconazole | 19 | 13 |
| Praluent Pen | Alirocumab | 19 | suppressed |
| Propylthiouracil | Propylthiouracil | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 18 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 18 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 15 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Humira(Cf) | Adalimumab | 14 | suppressed |
| Timolol Maleate | Timolol Maleate | 14 | suppressed |
| Trimethoprim | Trimethoprim | 14 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 13 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 12 |
| Linzess | Linaclotide | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Trandolapril | Trandolapril | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Nadolol | Nadolol | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $87.87 · 6 records | Boehringer Ingelheim Pharmaceuticals, Inc. | FARXIGA, JARDIANCE, The Cologuard Plus Collection Kit, VOQUEZNA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error